Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/0269881119889296
PubMed Identifier: 31829775
Publication URI: http://europepmc.org/abstract/MED/31829775
Type: Journal Article/Review
Volume: 34
Parent Publication: Journal of psychopharmacology (Oxford, England)
Issue: 1
ISSN: 0269-8811